International Journal of Pharmaceutical Science and Research

International Journal of Pharmaceutical Science and Research


International Journal of Pharmaceutical Science and Research
International Journal of Pharmaceutical Science and Research
Vol. 7, Issue 3 (2022)

Review on allergic rhinitis


Amit Sanjay Hegade, Ajay Ramesh Gaikwad, Nayan Kishor Agrawal

Allergic rhinitis is a very common disorder that affects people of all ages. It is strongly linked to asthma and conjunctivitis. It is ignored, underdiagnosed, misdiagnosed, and mistreated. Allergic rhinitis is not a serious illness. but, major risk is that poor asthma control and affects quality of life and productivity at work or school. Allergic rhinitis is shows same symptoms as common cold. so, difficult to identify.to confirm the diagnosis, specific IgE reactivity needs to be recorded. Many classes of drug are available, effective, and safe. In meta-analyses, intranasal corticosteroids are superior to other treatments, have a good safety profile, and treat all symptoms of allergic rhinitis effectively. First-generation antihistamines are associated with sedation, psychomotor retardation, and reduced academic performance. Third-generation antihistamines shows less sedation. Proper management of drugs must follows for reduced sedation and side effects.
Download  |  Pages : 36-41
How to cite this article:
Amit Sanjay Hegade, Ajay Ramesh Gaikwad, Nayan Kishor Agrawal. Review on allergic rhinitis. International Journal of Pharmaceutical Science and Research, Volume 7, Issue 3, 2022, Pages 36-41
International Journal of Pharmaceutical Science and Research